Pfizer to pay $35 million to settle hormone claims
- Share via
Pfizer Inc. agreed to pay $34.7 million in fines to settle Justice Department allegations that it improperly promoted the human growth hormone product Genotropin.
The drug maker’s Pharmacia & Upjohn Co. subsidiary pleaded guilty to offering a kickback to a pharmacy benefit manager to sell more of the drug and agreed to pay a $19.7-million fine. As part of the agreement, the Pharmacia unit will be barred from federal healthcare programs.
New York-based Pfizer will also pay $15 million for promotion of Genotropin for uses not approved by the Food and Drug Administration.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
